# Sodium Oxybate in the Treatment of Binge Eating Disorder

> **NCT00514995** · PHASE2,PHASE3 · COMPLETED · sponsor: **Lindner Center of HOPE** · enrollment: 15 (estimated)

## Conditions studied

- Binge Eating Disorder

## Interventions

- **DRUG:** Sodium Oxybate

## Key facts

- **NCT ID:** NCT00514995
- **Lead sponsor:** Lindner Center of HOPE
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2011-06-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00514995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00514995, "Sodium Oxybate in the Treatment of Binge Eating Disorder". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00514995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*